LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Biomedical Research Advanced by Technology That Sees Through Organs

By LabMedica International staff writers
Posted on 24 Aug 2014
Image: 3D visualization of intact kidney tissue, obtained through the whole-body clearing and staining PARS method (Photo courtesy of Bin Yang and Viviana Gradinaru, Caltech).
Image: 3D visualization of intact kidney tissue, obtained through the whole-body clearing and staining PARS method (Photo courtesy of Bin Yang and Viviana Gradinaru, Caltech).
Image: 3D visualization of intact intestine tissue, obtained through the whole-body clearing and staining PARS method (Photo courtesy of Bin Yang and Viviana Gradinaru, Caltech).
Image: 3D visualization of intact intestine tissue, obtained through the whole-body clearing and staining PARS method (Photo courtesy of Bin Yang and Viviana Gradinaru, Caltech).
Image: (A and B) The (A) dorsal and (B) ventral view of whole Thy1-eYFP mouse after PARS clearing with 8% SDS for one week showed good optical transparency of whole body. Arrowhead in (B) points to cleared kidney. (C) The image of the brain for the same mouse. Images were taken using bright field camera (Photo courtesy of Cell, Yang et al, Caltech).
Image: (A and B) The (A) dorsal and (B) ventral view of whole Thy1-eYFP mouse after PARS clearing with 8% SDS for one week showed good optical transparency of whole body. Arrowhead in (B) points to cleared kidney. (C) The image of the brain for the same mouse. Images were taken using bright field camera (Photo courtesy of Cell, Yang et al, Caltech).
The capability to see through organs and even the entire body to visualize long-range connections between cells, as well as the subtle aspects of cellular structures has been a long-time quest for biologists. A study has now made this a reality, revealing simple ways for making opaque organs, bodies, and human tissue biopsies transparent, while keeping the cellular structures and connections intact.

The protocols could create avenues for a better determination of brain-body interactions, more accurate clinical diagnoses and disease monitoring, and a new generation of therapies for disorders ranging from autism to chronic pain. “Although the idea of tissue clearing has been around for a century, to our knowledge, this is the first study to perform whole-body clearing, as opposed to first extracting and then clearing organs outside the adult body,” said senior study author Dr. Viviana Gradinaru of the California Institute of Technology (Caltech; Pasadena, USA). The findings were published July 31, 2014, in the journal Cell. “Our methodology has the potential to accelerate any scientific endeavor that would benefit from whole-organism mapping, including the study of how peripheral nerves and organs can profoundly affect cognition and mental processing, and vice versa.”

Three-dimensional maps of intact organs and bodies are key for understanding complex, long-distance cellular interactions that play an important role in a range of biological processes. But until now, methods for making whole organs or bodies transparent and thus amenable to imaging and generating three-dimensional (3D) maps have been limited to the brain or embryos. Dr. Gradinaru and her collaborators earlier developed a brain-clearing technique called CLARITY (Clear, Lipid-exchanged, Acrylamide-hybridized Rigid, Imaging/immunostaining compatible, Tissue hYdrogel), which involves embedding tissue into hydrogels to preserve its 3D structure and important molecular features, and then using detergents to extract lipids that make the tissue opaque.

In the new study, the researchers set out to make CLARITY suitable for whole organs and bodies, in part by making the process faster. First, they identified the optimal hydrogel that allows detergents to quickly remove lipids from tissue using an approach named passive CLARITY technique (PACT). To great speed up the clearing process without causing tissue damage, they introduced an advanced procedure called perfusion-assisted agent release in situ (PARS), which involves directly delivering the hydrogel and clearing reagents into the bloodstream of intact rodents. The reagents diffused throughout the tissues and fully clarified organs such as the kidney, heart, lung, and intestine within two to three days, while the whole brain and entire body cleared within two weeks.

The researchers also developed a recipe for refractive index matching solution (RIMS), which enables the long-term storage of cleared tissue and imaging thick, cleared tissue using a traditional confocal microscope. The new technologies allow for the study of intact connections between cells as well as structures and molecules within single cells using standard genetic and molecular biology techniques. “Our easy-to-use tissue clearing protocols, which employ readily available and cost-effective reagents and equipment, will make the subcellular interrogation of large tissue samples an accessible undertaking within the broader research and clinical communities,” Dr. Gradinaru said.

Related Links:

California Institute of Technology


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Silver Member
PCR Plates
Diamond Shell PCR Plates

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more